An Analysis of the Influence of a Patient’s Sex on Quality of Life in Liver and Kidney Transplantation
Abstract
:1. Introduction
2. Materials and Methods
- −
- −
- Sociodemographic variables: Sociodemographic variables such as sex, age, marital status, level of education, type of occupation, and level of income.
- −
- Clinical variables: Etiology of the disease, age at diagnosis, length of time with the illness and deterioration, hospitalizations in the last year and causes, days at the hospital, packs of tobacco consumed per year, consumption of other psychotropic drugs, years of alcohol consumption, and standard drink units per day. Sociodemographic and clinical variables were recorded in the data research collection of the previous study.
- −
- −
- −
- Socio-family support: This variable was evaluated through the use of the Perception of Social and Family Support Scale (EASP) [24].
- −
- Coping strategies: This variable was evaluated using the Coping Strategies Questionnaire (CEA) [25].
3. Results
3.1. Sociodemographic Characteristics for Liver Patients
3.2. Clinical Characteristics for Liver Patients
3.3. Psychological Characteristics for Liver Patients
3.4. Quality of Life for Liver Patients
3.5. Sociodemographic Characteristics for Kidney Patients
3.6. Clinical Characteristics for Kidney Patients
3.7. Psychological Characteristics for Kidney Patients
3.8. Quality of Life for Kidney Patients
3.9. Post-Transplantation Study
4. Discussion
- (a)
- Quality of life is an essential marker in the study of liver and kidney transplantations, and its combination with sociodemographic, clinical, and psychological factors can be useful in the identification of specific intervention areas according to the sex and gender of the patient.
- (b)
- No significant differences were found in the overall indices of physical and mental quality of life between sexes in the context of liver and kidney transplants, except in the case of pain in liver transplantation. The presence of greater physical limitation and social function pre-transplant and the significant difference in the perception of pain in women points to the need for strategies to improve quality of life.
- (c)
- The understanding of the impact of gender on the quality of life of transplanted patients is limited by cultural differences and a lack of studies with a gender perspective. Therefore, more studies must be conducted in this area to enable more effective and personalized health care.
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Lee, S.K. Sex as an important biological variable in biomedical research. BMB Rep. 2018, 51, 167–173. [Google Scholar] [CrossRef]
- Mauvais-Jarvis, F.; Merz, N.B.; Barnes, P.J.; Brinton, R.D.; Carrero, J.-J.; DeMeo, D.L.; De Vries, G.J.; Epperson, C.N.; Govindan, R.; Klein, S.L.; et al. Sex and gender: Modifiers of health, disease, and medicine. Lancet 2020, 396, 565–582. [Google Scholar] [CrossRef]
- Wang, H.; Zhang, X.; Li, H.; Sun, Z.; Zhong, Y. Gender differences in the burden of multiple sclerosis in China from 1990 to 2019 and its 25-year projection: An analysis of the Global Burden of Diseases Study. Health Sci. Rep. 2023, 6, e1738. [Google Scholar] [CrossRef]
- Cherepanov, D.; Palta, M.; Fryback, D.G.; Robert, S.A.; Hays, R.D.; Kaplan, R.M. Gender Differences in Multiple Underlying Dimensions of Health-related Quality of Life Are Associated with Sociodemographic and Socioeconomic Status. Med. Care 2011, 49, 1021–1030. [Google Scholar] [CrossRef]
- Ordin, Y.S.; Dicle, A.; Wellard, S. Quality of Life in Recipients before and after Liver Transplantation in Turkey. Prog. Transplant. 2011, 21, 260–267. [Google Scholar] [CrossRef]
- Maenosono, R. Sex difference and immunosenescence affect transplantation outcomes. Front. Transplant. 2023, 2, 1235740. [Google Scholar] [CrossRef]
- Gordon, E.J.; Ladner, D.P. Gender Inequities Pervade Organ Transplantation Access. Transplantation 2012, 94, 447–448. [Google Scholar] [CrossRef]
- Puoti, F.; Ricci, A.; Nanni-Costa, A.; Ricciardi, W.; Malorni, W.; Ortona, E. Organ transplantation and gender differences: A paradigmatic example of intertwining between biological and sociocultural determinants. Biol. Sex Differ. 2016, 7, 35. [Google Scholar] [CrossRef]
- Salas, M.A.P.; Chua, E.; Rossi, A.; Shah, S.; Katz-Greenberg, G.; Coscia, L.; Sawinski, D.; Adey, D. Sex and gender disparity in kidney transplantation: Historical and future perspectives. Clin. Transplant. 2022, 36, e14814. [Google Scholar] [CrossRef] [PubMed]
- Alkatheri, A.; Al Bekairy, A.; Aburuz, S.; Qandil, A.; Khalidi, N.; Abdullah, K.; Al Sayyari, S.; Bustami, R.; Al Harbi, S.; Al Raddadi, S.; et al. Exploring quality of life among renal and liver transplant recipients. Ann. Saudi Med. 2015, 35, 368–376. [Google Scholar] [CrossRef] [PubMed]
- Corruble, E.; Barry, C.; Varescon, I.; Durrbach, A.; Samuel, D.; Lang, P.; Castaing, D.; Charpentier, B.; Falissard, B. Report of depressive symptoms on waiting list and mortality after liver and kidney transplantation: A prospective cohort study. BMC Psychiatry 2011, 11, 182. [Google Scholar] [CrossRef] [PubMed]
- Melk, A.; Babitsch, B.; Borchert-Mörlins, B.; Claas, F.; Dipchand, A.I.; Eifert, S.; Eiz-Vesper, B.; Epping, J.; Falk, C.S.; Foster, B.; et al. Equally Interchangeable? How Sex and Gender Affect Transplantation. Transplantation 2019, 103, 1094–1110. [Google Scholar] [CrossRef] [PubMed]
- Schneekloth, T.D.; Hitschfeld, M.J.; Petterson, T.M.; Narayanan, P.; Niazi, S.K.; Jowsey-Gregoire, S.G.; Thusius, N.J.; Vasquez, A.R.; Kremers, W.K.; Watt, K.D.; et al. Psychosocial Risk Impacts Mortality in Women After Liver Transplantation. Psychosomatics 2018, 60, 56–65. [Google Scholar] [CrossRef]
- Sainz-Barriga, M.; Baccarani, U.; Scudeller, L.; Risaliti, A.; Toniutto, P.; Costa, M.; Ballestrieri, M.; Adani, G.; Lorenzin, D.; Bresadola, V.; et al. Quality-of-Life Assessment Before and After Liver Transplantation. Transplant. Proc. 2005, 37, 2601–2604. [Google Scholar] [CrossRef]
- Ruiz, D.D.; Aguirre, C.F.; González, F.S.; Ruiz, M.C. Indicaciones y resultados a largo plazo de los trasplantes de órganos sólidos. Calidad de vida en pacientes trasplantados. Med. Intensiv. 2008, 32, 296–303. [Google Scholar] [CrossRef]
- Londoño Ramírez, A.C. Influencia de Los Patrones Psiquiátricos y Psicológicos Sobre la Calidad de Vida en el Trasplante Renal y Hepático [Tesis en Internet]. Alicante: Universidad Miguel Hernández de Elche. 2017. Available online: https://dspace.umh.es/bitstream/11000/4401/1/TD%20Londo%C3%B1o%20Ram%C3%ADrez%2C%20Ana%20Carolina.pdf (accessed on 30 April 2024).
- Tarabeih, M.; Bokek-Cohen, Y.; Azuri, P. Health-related quality of life of transplant recipients: A comparison between lung, kidney, heart, and liver recipients. Qual. Life Res. 2020, 29, 1631–1639. [Google Scholar] [CrossRef]
- Ware, J.E.; Kosinski, M.; Dewey, J.E.; Gandek, B. SF-36 Health Survey: Manual and Interpretation Guide; Quality Metric Inc.: Johnston, RI, USA, 2000. [Google Scholar]
- Zigmond, A.S.; Snaith, R.P. The Hospital Anxiety and Depression Scale. Acta Psychiatr. Scand. 1983, 67, 361–370. [Google Scholar] [CrossRef] [PubMed]
- Alonso, J.; Prieto, L.; Antó, J.M. La versión española del SF-36 Health Survey (Cuestionario de Salud SF-36): Un instrumento para la medida de los resultados clínicos. Med. Clin. 1995, 104, 771–776. [Google Scholar]
- Eysenk, H.J.; Eysenk, S.B.G. Manual of the Eysenck Personality Inventory; University of London Press: London, UK, 1964. [Google Scholar]
- Sánchez, M.; Cuadras, C. Adaptación española del cuestionario E.P.I. de Eysenck. Anu. Psicol. 1972, 6, 31–59. [Google Scholar]
- Terol, M.C.; López-Roig, S.; Rodríguez-Marín, J.; Martí-Aragón, M.; Pastor, M.A.; Reig, M.T. Propiedades psicométricas de la escala hospitalaria de ansiedad y depresión (HAD) en población española. Ansiedad Estrés 2007, 13, 163–173. [Google Scholar]
- Terol, M.C.; López-Roig, S.; Pastor, M.A.; Leyda, J.I.; Neipp, M.C.; Rodríguez-Marín, J. Evaluación de las dimensiones de apoyo social en pacientes oncológicos. Rev. Psicol. Soc. Apl. 2000, 10, 63–79. [Google Scholar]
- Rodríguez-Marín, J.; Terol, M.C.; López-Roig, S.; Pastor, M.A. Evaluación del afrontamiento del estrés: Propiedades psicométricas del cuestionario de formas de afrontamiento de acontecimientos estresantes. Rev. Psicol. Salud. 1992, 4, 59–84. [Google Scholar]
- Cowling, T.; Jennings, L.W.; Goldstein, R.M.; Sanchez, E.Q.; Chinnakotla, S.; Klintmalm, G.B.; Levy, M.F. Liver transplantation and health-related quality of life: Scoring differences between men and women. Liver Transplant. 2004, 10, 88–96. [Google Scholar] [CrossRef] [PubMed]
- Ozdemir, A.A.; Sayin, C.B.; Erdal, R.; Ozcan, C.; Haberal, M. Quality of Life Through Gender Role Perspective in Candidate Renal Transplant Recipients: A Report From Baskent University Using the Short Form 36 Health Survey. Exp. Clin. Transplant. 2018, 16, 28–34. [Google Scholar] [CrossRef]
- Dąbrowska-Bender, M.; Michałowicz, B.; Pączek, L. Assessment of the Quality of Life in Patients After Liver Transplantation as an Important Part of Treatment Results. Transplant. Proc. 2016, 48, 1697–1702. [Google Scholar] [CrossRef] [PubMed]
- Bianco, T.; Cillo, U.; Amodio, P.; Zanus, G.; Salari, A.; Neri, D.; Bombonato, G.; Schiff, S.; Baggio, G.; Ronco, C.; et al. Gender differences in the quality of life of patients with liver cirrhosis related to hepatitis C after liver transplantation. Blood Purif. 2013, 36, 231–236. [Google Scholar] [CrossRef]
- Blanch, J.; Sureda, B.; Flaviá, M.; Marcos, V.; de Pablo, J.; De Lazzari, E.; Rimola, A.; Vargas, V.; Navarro, V.; Margarit, C.; et al. Psychosocial adjustment to orthotopic liver transplantation in 266 recipients. Liver Transplant. 2004, 10, 228–234. [Google Scholar] [CrossRef]
- Ministerio de Sanidad. Encuesta Sobre el Alcohol y Otras Drogas en España (EDADES), 1996–2022. España: Delegación del Gobierno Para el Plan Nacional Sobre Drogas. 2023, 12–18. Available online: https://pnsd.sanidad.gob.es/profesionales/sistemasInformacion/sistemaInformacion/encuestas_EDADES.htm (accessed on 27 April 2024).
- Cho, S.; Park, S.; Kim, J.E.; Yu, M.-Y.; Baek, S.H.; Han, K.; Lee, H.; Kim, D.K.; Joo, K.W.; Kim, Y.S.; et al. Incidence of depression in kidney transplant recipients in South Korea: A long-term population-based study. Sci. Rep. 2022, 12, 17603. [Google Scholar] [CrossRef]
- Craig, J.A.; Miner, D.; Remtulla, T.; Miller, J.; Zanussi, L.W. Piloting a Coping Skills Group Intervention to Reduce Depression and Anxiety Symptoms in Patients Awaiting Kidney or Liver Transplant. Health Soc. Work. 2016, 42, e44–e52. [Google Scholar] [CrossRef]
- Heidari, S.; Babor, T.F.; De Castro, P.; Tort, S.; Curno, M. Sex and Gender Equity in Research: Rationale for the SAGER guidelines and recommended use. Res. Integr. Peer Rev. 2016, 1, 2. [Google Scholar] [CrossRef]
Variables | Men (n = 58) | Women (n = 12) | p-Value |
---|---|---|---|
Sociodemographic characteristics | |||
Age (years); mean (SD) | 54.57 (8.21) | 60.75 (4.55) | 0.040 ** |
Age at diagnosis (years); mean (SD) | 46.26 (10.48) | 45.42 (13.95) | 0.322 |
Clinical features/use of psychotropic drugs | |||
Length of time with illness (months); mean (SD) | 8.31 (8.60) | 15.33 (13.70) | 0.013 ** |
Etiology; n (%) | |||
Alcohol | 40 (70.2%) | 4 (36.4%) | 0.007 ** |
Viral | 10 (17.5%) | 4 (36.4%) | |
Polycystic disease | 0 (0%) | 2 (18.2%) | |
Cancer | 5 (8.8%) | 1 (9.1%) | |
Causes of hospitalization; n (%) | |||
Infection | 9 (19.1%) | 1 (10%) | 0.025 ** |
Encephalopathy | 9 (19.1%) | 2 (20%) | |
Esophageal varices | 8 (17%) | 0 (0%) | |
Ascites | 5 (10.6%) | 5 (50%) | |
Alcohol consumption (years); mean (SD) | 32.67 (32.77) | 8.33 (12.70) | 0.807 |
SDU (g/day); mean (DS) | 126.66 (122.16) | 32.92 (91.16) | 0.065 |
Smoker; n (%) | 47 (81%) | 6 (50%) | 0.022 ** |
Other psychotropic drugs; n (%) | 19 (32.8%) | 0 (0%) | 0.020 ** |
Psychological characteristics | |||
Anxiety disorder; n (%) | 11 (19%) | 3 (25%) | 0.634 |
Depressive disorder; n (%) | 12 (20.7%) | 5 (41.7%) | 0.123 |
Neuroticism; n (%) | |||
Low | 26 (44.8%) | 2 (16.7%) | 0.101 |
Medium | 8 (13.8%) | 1 (8.3%) | |
High | 24 (41.4%) | 9 (75%) | |
Extroversion; n (%) | |||
Low | 20 (34.5%) | 6 (50%) | 0.509 |
Medium | 11 (19%) | 1 (8.1%) | |
High | 27 (46.6%) | 5 (41.7%) | |
Number of providers; mean (SD) | 5.52 (2.11) | 4.67 (2.06) | 0.980 |
Satisfaction with support; mean (SD) | 4.30 (0.59) | 4.44 (0.47) | 0.346 |
Level of support; mean (SD) | 23.60 (9.72) | 20.58 (8.49) | 0.718 |
Positive thinking; n (%) | 56 (96.6%) | 12 (100%) | 0.514 |
Searching for advantages; n (%) | 51 (87.9%) | 11 (91.7%) | 0.711 |
Resignation; n (%) | 46 (79.3%) | 12 (100%) | 0.083 |
Searching for support; n (%) | 41 (70.7%) | 11 (91.7%) | 0.130 |
Searching for solutions; n (%) | 40 (69%) | 9 (75%) | 0.678 |
Wishful thinking; n (%) | 45 (77.6%) | 12 (100%) | 0.069 |
Repress emotions; n (%) | 44 (75.9%) | 8 (66.7%) | 0.507 |
Self-blame; n (%) | 43 (74.1%) | 5 (41.7%) | 0.027 ** |
Religiousness; n (%) | 27 (46.6%) | 9 (75%) | 0.073 |
Escapism; n (%) | 32 (55.2%) | 4 (33.3%) | 0.168 |
Blaming others; n (%) | 18 (31%) | 4 (33.3%) | 0.876 |
Quality of Life Items (SF-36) | Men (n = 58) | Women (n = 12) | p-Value |
---|---|---|---|
Physical function; mean (SD) | 65.23 (23.70) | 42.08 (26.58) | 0.651 |
Physical limitation; mean (SD) | 42.24 (42.45) | 16.67 (38.92) | 0.048 ** |
Body pain; mean (SD) | 47.05 (14.49) | 31.58 (31.01) | <0.001 ** |
General perception of health; mean (SD) | 43.38 (20.54) | 38.33 (20.44) | 0.918 |
Vitality; mean (SD) | 46.21 (30.42) | 31.67 (27.47) | 0.853 |
Social function; mean (SD) | 71.01 (28.11) | 38.54 (33.05) | 0.660 |
Mental health; mean (SD) | 65.12 (26.89) | 57.67 (21.06) | 0.387 |
Emotional limitation; mean (SD) | 78.97 (37.08) | 61.08 (44.61) | 0.142 |
Physical health summary; mean (SD) | 36.80 (9.49) | 32.87 (13.85) | 0.104 |
Mental health summary; mean (SD) | 46.46 (11,75) | 37.25 (13.03) | 0.398 |
Variables | Men (n = 46) | Women (n = 31) | p-Value |
---|---|---|---|
Sociodemographic characteristics | |||
Age (years); mean (SD) | 51.28 (12.45) | 54 (12.25) | 0.384 |
Age at diagnosis (years); mean (SD) | 41.22 (17.22) | 39.97 (16.38) | 0.753 |
Clinical features/use of psychotropic drugs | |||
Length of time with illness (months); mean (SD) | 12.24 (10.37) | 14.03 (10.28) | 0.648 |
Etiology; n (%) | |||
GMN | 17 (37%) | 6 (19.4%) | 0.012 ** |
HTA | 10 (21.7%) | 2 (6.5%) | |
Polycystic disease | 3 (6.5%) | 12 (38.7%) | |
DM | 5 (10.9%) | 4 (12.9%) | |
Causes of hospitalization; n (%) | |||
Infection | 10 (34.5%) | 5 (29.4%) | 0.610 |
Surgery | 9 (31%) | 7 (41.2%) | |
Alt.FR | 3 (10.3%) | 2 (11.8%) | |
HTA/DM | 2 (6.9%) | 3 (17.6%) | |
Dialysis; n (%) | 34 (73.9%) | 28 (90.3%) | 0.075 |
Alcohol consumption (years); mean (SD) | 21.43 (17.93) | 6 (13.17) | 0.005 ** |
SDUs (g/day); mean (SD) | 31.02 (34.20) | 7.13 (19.52) | 0.001 ** |
Smoker; n (%) | 33 (71.7%) | 19 (61.3%) | 0.337 |
Other psychotropic drugs; n (%) | 4 (8.7%) | 0 (0%) | 0.092 |
Psychological characteristics | |||
Anxiety disorder; n (%) | 8 (17.4%) | 7 (22.6%) | 0.573 |
Depressive disorder; n (%) | 3 (6.5%) | 5 (16.1%) | 0.175 |
Neuroticism; n (%) | |||
Low | 28 (60.9%) | 17 (54.8%) | 0.567 |
Medium | 5 (10.9%) | 2 (6.5%) | |
High | 13 (28.3%) | 12 (38.7%) | |
Extroversion; n (%) | |||
Low | 14 (30.4%) | 6 (19.4%) | 0.503 |
Medium | 5 (10.9%) | 5 (16.1%) | |
High | 27 (58.7%) | 20 (64.5%) | |
Number of providers; mean (SD) | 5.28 (2.05) | 5.84 (1.71) | 0.318 |
Satisfaction with support; mean (SD) | 4.33 (0.62) | 4.21 (0.48) | 0.492 |
Level of support; mean (SD) | 22.78 (9.41) | 24.68 (7.94) | 0.359 |
Positive thinking; n (%) | 46 (100%) | 29 (93.5%) | 0.081 |
Searching for advantages; n (%) | 43 (93.5%) | 31 (100%) | 0.147 |
Resignation; n (%) | 33 (71.7%) | 26 (83.9%) | 0.217 |
Searching for support; n (%) | 34 (73.9%) | 25 (80.6%) | 0.494 |
Searching for solutions; n (%) | 34 (73.9%) | 24 (77.4%) | 0.726 |
Wishful thinking; n (%) | 28 (60.9%) | 22 (71%) | 0.362 |
Repress emotions; n (%) | 39 (84.8%) | 23 (74.2%) | 0.250 |
Self-blame; n (%) | 10 (21.7%) | 5 (16.1%) | 0.542 |
Religiousness; n (%) | 6 (13%) | 23 (74.2%) | <0.001 ** |
Escapism; n (%) | 15 (32.6%) | 13 (41.9%) | 0.404 |
Blaming others; n (%) | 9 (19.6%) | 5 (16.1%) | 0.701 |
Quality of Life Items (SF-36) | Men (n = 46) | Women (n = 31) | p-Value |
---|---|---|---|
Physical function; mean (SD) | 72.27 (21.41) | 67.50 (20.64) | 0.640 |
Physical limitation; mean (SD) | 54.89 (44.29) | 52.42 (42.00) | 0.312 |
Body pain; mean (SD) | 54.93 (20.17) | 55.06 (19.41) | 0.475 |
General perception of health; mean (SD) | 53.63 (20.36) | 50.52 (19.66) | 0.831 |
Vitality; mean (SD) | 58.15 (21.94) | 54.68 (27.44) | 0.169 |
Social function; mean (SD) | 80.16 (24.51) | 77.01 (25.43) | 0.735 |
Mental health; mean (SD) | 76.70 (17.22) | 67.58 (25.18) | 0.068 |
Emotional limitation; mean (SD) | 90.59 (26.91) | 84.97 (34.24) | 0.132 |
Physical health summary; mean (SD) | 40.01 (8.83) | 39.82 (7.34) | 0.105 |
Mental health summary; mean (SD) | 51.89 (9.28) | 48.71 (12.82) | 0.143 |
Quality of Life Items (SF-36) | Baseline Measurements | Measurement After 6 Months | p-Value Sex | p-Value Time | ||
---|---|---|---|---|---|---|
Men (n = 31) | Women (n = 6) | Men (n = 31) | Women (n = 6) | |||
Physical function; mean (SD) | 67.19 (22.40) | 50.83 (23.96) | 71.93 (22.23) | 70.00 (11.83) | 0.127 | 0.254 |
Physical limitation; mean (SD) | 45.96 (44.29) | 16.67 (40.82) | 49.45 (45.74) | 18.00 (21.30) | 0.127 | 0.534 |
Body pain; mean (SD) | 46.22 (13.85) | 28.00 (28.00) | 55.35 (17.42) | 43.33 (29.84) | 0.011 ** | 0.099 |
General perception of health; mean (SD) | 44.19 (19.00) | 35.33 (22.86) | 71.83 (18.82) | 66.00 (32.58) | 0.071 | <0.001 ** |
Vitality; mean (SD) | 51.29 (29.21) | 32.50 (31.42) | 63.06 (22.82) | 60.83 (20.10) | 0.195 | 0.025 ** |
Social function; media (DS) | 71.61 (29.56) | 31.33 (31.47) | 80.00 (26.67) | 64.83 (38.30) | 0.006 ** | 0.070 |
Mental health; mean (SD) | 61.93 (26.75) | 63.33 (20.14) | 74.96 (20.68) | 62.66 (24.61) | 0.344 | 0.401 |
Emotional limitation; mean (SD) | 70.96 (41.07) | 72.16 (32.92) | 77.41 (38.87) | 50.00 (45.99) | 0.817 | 0.224 |
Physical health summary; mean (SD) | 38.83 (8.28) | 35.00 (16.29) | 42.61 (7.40) | 40.00 (3.68) | 0.189 | 0.259 |
Mental health summary; mean (SD) | 44.96 (12.77) | 36.16 (8.56) | 50.19 (11.26) | 42.50 (16.62) | 0.083 | 0.055 |
Quality of Life Items (SF-36) | Baseline Measurements | Measurement After 6 Months | p-Value Sex | p-Value Time | ||
---|---|---|---|---|---|---|
Men (n = 26) | Women (n = 16) | Men (n = 26) | Women (n = 16) | |||
Physical function; mean (SD) | 74.61 (17.82) | 70.31 (16.57) | 71.53 (19.01) | 68.75 (20.12) | 0.298 | 0.085 |
Physical limitation; mean (SD) | 54.80 (44.73) | 48.43 (40.27) | 50.96 (47.68) | 51.56 (45.15) | 0.995 | 0.006 ** |
Body pain; mean (SD) | 55.00 (20.99) | 52.56 (17.36) | 57.84 (22.25) | 51.87 (20.61) | 0.754 | 0.601 |
General perception of health; mean (SD) | 56.38 (19.27) | 51.18 (20.27) | 65.53 (20.53) | 66.62 (22.14) | 0.483 | 0.014 ** |
Vitality; mean (SD) | 56.34 (18.14) | 56.25 (30.46) | 63.07 (20.69) | 52.50 (23.30) | 0.200 | 0.592 |
Social function; media (DS) | 82.30 (23.98) | 74.50 (26.63) | 79.07 (20.73) | 76.00 (28.50) | 0.400 | 0.004 ** |
Mental health; mean (SD) | 77.84 (16.40) | 65.18 (28.05) | 76.30 (18.92) | 76.00 (18.30) | 0.128 | 0.606 |
Emotional limitation; mean (SD) | 93.61 (21.08) | 87.50 (34.15) | 91.03 (24.14) | 70.81 (45.35) | 0.107 | 0.398 |
Physical health summary; mean (SD) | 40.34 (8.36) | 39.81 (8.24) | 41.38 (9.45) | 41.87 (9.45) | 0.916 | 0.047 ** |
Mental health summary; mean (SD) | 52.34 (8.95) | 48.37 (13.38) | 52.34 (9.05) | 48.12 (11.87) | 0.092 | 0.778 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Campillo Amo, N.; Martínez, E.P.; Gomis, A.v.-d.H.; Ramírez, A.C.L.; Román, C.J.v.-d.H. An Analysis of the Influence of a Patient’s Sex on Quality of Life in Liver and Kidney Transplantation. Healthcare 2024, 12, 2116. https://doi.org/10.3390/healthcare12212116
Campillo Amo N, Martínez EP, Gomis Av-dH, Ramírez ACL, Román CJv-dH. An Analysis of the Influence of a Patient’s Sex on Quality of Life in Liver and Kidney Transplantation. Healthcare. 2024; 12(21):2116. https://doi.org/10.3390/healthcare12212116
Chicago/Turabian StyleCampillo Amo, Naiara, Enrique Pérez Martínez, Ana van-der Hofstadt Gomis, Ana Carolina Londoño Ramírez, and Carlos J. van-der Hofstadt Román. 2024. "An Analysis of the Influence of a Patient’s Sex on Quality of Life in Liver and Kidney Transplantation" Healthcare 12, no. 21: 2116. https://doi.org/10.3390/healthcare12212116
APA StyleCampillo Amo, N., Martínez, E. P., Gomis, A. v.-d. H., Ramírez, A. C. L., & Román, C. J. v.-d. H. (2024). An Analysis of the Influence of a Patient’s Sex on Quality of Life in Liver and Kidney Transplantation. Healthcare, 12(21), 2116. https://doi.org/10.3390/healthcare12212116